Sumary of Promising results for mixing Pfizer, AstraZeneca in German trial, as Aussie experts cite ‘positive signs’:
- It’s at least the third trial this year to show the potential benefits of mixing vaccines following reports from Madrid’s Carlos III Health Institute in May and a University of Oxford paper released in June.
- In controlled studies, they both showed a better immune response by mixing the two schedules, and researchers at Saarland University in Homburg, Germany, have had similar results.
- “Saarland University in Homburg, Germany, found that the mixed regimen was better at eliciting an immune response than were two Oxford-AstraZeneca shots.
- Infectious diseases professor Peter Collignon said it was promising although more and extensive studies were needed on long term benefits as well as side effects.
- Camera IconProfessor Peter Collignon, from the Australian National University Medical School in Canberra, says initial studies are promising.
- The peer-reviewed medical journal The Lancet also published findings from an Oxford and Nottingham University study involving more than 460 participants that showed an increase in immunity when a Pfizer inoculation followed an AstraZeneca jab.
- A cocktail of AstraZeneca and Pfizer vaccines may be beneficial in the short term but it was also about the long term benefits, said Immunisation Coalition chair Rod Pearce said.
- “The figures look good but we don’t know if it relates to long-term protection,” Dr Pearce said.